DEF: SCYNEXIS, Inc. Announces Annual Meeting of Stockholders to be Held Virtually on June 25, 2025

SCYNEXIS, Inc. will hold its 2025 Annual Meeting of Stockholders virtually on June 25, 2025, to vote on director elections, auditor ratification, executive compensation, and other business.

Summary

• SCYNEXIS, Inc. is holding its 2025 Annual Meeting of Stockholders on June 25, 2025, at 9:30 a.m. Eastern time, as a virtual meeting.
• Stockholders of record as of April 28, 2025, are eligible to vote.
• The meeting agenda includes the election of seven directors, ratification of Deloitte & Touche LLP as the independent accounting firm for the fiscal year ending December 31, 2025, and an advisory vote on executive compensation.
• The Board of Directors recommends voting FOR all director nominees and FOR the ratification of the accounting firm and the advisory vote on executive compensation.
• Stockholders can vote online, by phone, or by mail, with proxy votes needing to be received by 11:59 p.m. Eastern Time on June 24, 2025.
• The company has hired Sodali & Co to aid in the solicitation of proxies for a fee of $7,000, plus reasonable out-of-pocket expenses.
• To be considered for inclusion in next year's proxy materials, stockholder proposals must be submitted in writing by December 30, 2025.
• As of the record date, 43% of the company's directors were women or racially or ethnically diverse individuals.
• The Board has determined that all directors other than Dr. Angulo, the president and chief executive officer, are independent directors.
• The company's Audit Committee consists of Ann F. Hanham, Ph.D., David Hastings, and Philippe Tinmouth, with Mr. Hastings serving as the chair.
• The Compensation Committee consists of Armando Anido, Steven C. Gilman, Ph.D., and Guy Macdonald.
• The Nominating and Corporate Governance Committee consists of Armando Anido, Steven C. Gilman, Ph.D., and Ann F. Hanham, Ph.D.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The recommendations are clear and the information is presented in a straightforward manner.

Positives

• The company is taking advantage of SEC rules to furnish proxy materials over the internet, reducing environmental impact and lowering costs.
• The Board has an active role in overseeing the management of the company's risks.
• The company has adopted a Code of Business Conduct and Ethics that applies to all officers, directors, and employees.
• The company has an Insider Trading Policy and a Policy Against Hedging Transactions.

Negatives

• One director, Mr. Hastings, was an executive officer of Unilife Corporation when it filed for voluntary bankruptcy in April 2017.
• If stockholders fail to ratify the selection of Deloitte & Touche LLP, the Audit Committee will reconsider whether or not to retain that firm.

Risks

• If any director nominee becomes unavailable for election, shares will be voted for a substitute nominee proposed by the company.
• The Board knows of no other matters that will be presented for consideration at the Annual Meeting, but if any other matters are properly brought before the meeting, the persons named in the proxy will vote on such matters in accordance with their best judgment.

Future Outlook

The Board of Directors is asking stockholders to indicate their support for the compensation of SCYNEXISs named executive officers and intends to consider the outcome of this vote when making future compensation decisions.

Management Comments

• The Board of Directors recommends that you vote FOR each of the SCYNEXIS Board of Directors seven nominees as directors as set forth in Proposal 1, and FOR each of Proposals 2 and 3, in each case as identified above.

Industry Context

This proxy statement is a standard document for publicly traded companies, outlining the matters to be voted on at the annual meeting and providing information about the company's directors, executive compensation, and corporate governance practices.

Comparison to Industry Standards

• The director compensation policy is typical for companies of similar size and stage in the biotechnology industry.
• The use of independent compensation consultants is a common practice to ensure that executive compensation is aligned with market standards.
• The virtual format of the annual meeting is becoming increasingly common, allowing for broader participation and cost savings.

Stakeholder Impact

• Shareholders are asked to vote on key proposals that will impact the direction and oversight of the company.
• The outcome of the executive compensation vote may influence future compensation decisions.
• Employees are indirectly affected by the decisions made at the annual meeting, as they impact the overall governance and strategy of the company.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold the Annual Meeting of Stockholders on June 25, 2025.
• The company will file a Form 8-K to report the final voting results within four business days after the Annual Meeting.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Board of Directors, Executive Compensation, Director Election, Audit Committee, Deloitte & Touche LLP, Corporate Governance, SCYNEXIS